NRC Health Deferred Income Tax Liabilities, Net
NRC Health (NRC) had Deferred Income Tax Liabilities, Net of $6.00 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-08-04
- 2026-06-30: Deferred Income Tax Liabilities, Net $6.00M.
- 2026-03-31: Deferred Income Tax Liabilities, Net $6.00M.
- 2025-12-31: Deferred Income Tax Liabilities, Net $5.98M.
- 2025-09-30: Deferred Income Tax Liabilities, Net $3.45M.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2026-06-30 | $6.00M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $6.00M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $5.98M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $3.45M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $3.50M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $5.39M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $3.53M 10-K · filed 2026-03-05 |
| 2024-09-30 | $4.13M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $4.00M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $3.89M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $4.14M 10-K · filed 2025-03-17 |
| 2023-09-30 | $4.54M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $4.52M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $4.89M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $5.27M 10-K · filed 2024-02-27 |
| 2022-09-30 | $5.24M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $5.73M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $6.51M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $7.00M 10-K · filed 2023-03-03 |
| 2021-09-30 | $7.15M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $7.41M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $7.41M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $7.26M 10-K · filed 2022-03-04 |
| 2020-09-30 | $7.26M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $7.73M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $7.70M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $7.40M 10-K · filed 2021-03-05 |
| 2018-12-31 | $6.28M 10-K · filed 2020-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |